• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经母细胞瘤,2.2024 年版,NCCN 肿瘤学临床实践指南。

Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

机构信息

1Abramson Cancer Center at the University of Pennsylvania | Children's Hospital of Philadelphia.

2St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

出版信息

J Natl Compr Canc Netw. 2024 Aug;22(6):413-433. doi: 10.6004/jnccn.2024.0040.

DOI:10.6004/jnccn.2024.0040
PMID:39151455
Abstract

Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.

摘要

神经母细胞瘤是儿童中诊断出的最常见的颅外实体瘤。本版 NCCN 神经母细胞瘤指南提供了神经母细胞瘤的诊断、风险分类和治疗建议。这些指南中的信息由 NCCN 神经母细胞瘤专家组制定,该专家组是一个由在神经母细胞瘤方面具有专业知识的代表组成的多学科小组,成员包括来自 NCCN 成员机构的儿科肿瘤学家、放射科医生、病理学家、外科医生和放射肿瘤学家。NCCN 指南中包含的循证和共识建议旨在指导临床医生为患有这种临床异质性疾病的患者选择最合适的治疗方法。

相似文献

1
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.神经母细胞瘤,2.2024 年版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2024 Aug;22(6):413-433. doi: 10.6004/jnccn.2024.0040.
2
Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.外阴癌临床实践指南(2017 年第 1 版),NCCN 肿瘤学临床实践指南
J Natl Compr Canc Netw. 2017 Jan;15(1):92-120. doi: 10.6004/jnccn.2017.0008.
3
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.肾癌,2017 年第 2 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2017 Jun;15(6):804-834. doi: 10.6004/jnccn.2017.0100.
4
Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.《小儿急性淋巴细胞白血病,第2.2025版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南》
J Natl Compr Canc Netw. 2025 Feb;23(2):41-62. doi: 10.6004/jnccn.2025.0006.
5
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.NCCN 指南®洞察:黑色素瘤:皮肤,第 2.2024 版。
J Natl Compr Canc Netw. 2024 Jul;22(5):290-298. doi: 10.6004/jnccn.2024.0036.
6
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.免疫治疗相关毒性管理,版本 1.2022,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2022 Apr;20(4):387-405. doi: 10.6004/jnccn.2022.0020.
7
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.《儿科中枢神经系统癌症,第2.2025版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南》
J Natl Compr Canc Netw. 2025 Mar;23(3):113-130. doi: 10.6004/jnccn.2025.0012.
8
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.《NCCN 肿瘤学临床实践指南:乳腺癌》第 3.2024 版。
J Natl Compr Canc Netw. 2024 Jul;22(5):331-357. doi: 10.6004/jnccn.2024.0035.
9
Optimizing the Clinical Utility of Biomarkers in Oncology: The NCCN Biomarkers Compendium.优化肿瘤学生物标志物的临床应用:美国国立综合癌症网络(NCCN)生物标志物汇编
Arch Pathol Lab Med. 2015 May;139(5):608-11. doi: 10.5858/arpa.2014-0146-RA. Epub 2014 Oct 21.
10
NCCN pediatric neuroblastoma practice guidelines. The National Comprehensive Cancer Network.美国国立综合癌症网络儿童神经母细胞瘤诊疗指南。美国国立综合癌症网络。
Oncology (Williston Park). 1996 Dec;10(12):1813-22.

引用本文的文献

1
Role of F-AlF-NOTATATE PET/CT in selecting pediatric neuroblastoma candidates for Lu-DOTATATE peptide receptor radionuclide therapy.F-氟代-AlF-奥曲肽PET/CT在选择接受镥-奥曲肽肽受体放射性核素治疗的小儿神经母细胞瘤患者中的作用。
Front Med (Lausanne). 2025 Aug 28;12:1615136. doi: 10.3389/fmed.2025.1615136. eCollection 2025.
2
M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma.M344抑制神经母细胞瘤中组蛋白去乙酰化酶相关表型和肿瘤生长。
Int J Mol Sci. 2025 Sep 1;26(17):8494. doi: 10.3390/ijms26178494.
3
Role and practical guidelines for the use of radiotherapy in neuroblastoma - a narrative review of literature and clinical trial protocols.
神经母细胞瘤放射治疗的作用及实用指南——文献与临床试验方案的叙述性综述
Rep Pract Oncol Radiother. 2025 Aug 7;30(3):424-438. doi: 10.5603/rpor.106279. eCollection 2025.
4
Patient Experience and Improvement Opportunities in Self-Administered, Large-Volume Subcutaneous Infusions at Home.居家自行进行大容量皮下注射的患者体验及改进机会
Patient Prefer Adherence. 2025 Aug 13;19:2459-2491. doi: 10.2147/PPA.S515565. eCollection 2025.
5
Evaluation and management of incomplete ovarian function suppression in premenopausal breast cancer patients receiving anti-hormone therapy.接受抗激素治疗的绝经前乳腺癌患者卵巢功能抑制不完全的评估与管理。
Breast Cancer Res. 2025 Aug 18;27(1):147. doi: 10.1186/s13058-025-01979-x.
6
The baseline F-FDG PET/CT imaging features in pediatric patients with congenital neuroblastoma.先天性神经母细胞瘤患儿的基线F-FDG PET/CT影像特征。
BMC Med Imaging. 2025 Aug 14;25(1):330. doi: 10.1186/s12880-025-01863-2.
7
Clinical value of I-metaiodobenzylguanidine single-photon emission computed tomography/computed tomography in spontaneous regression of localized congenital neuroblastoma: an evaluative study.间碘苄胍单光子发射计算机断层扫描/计算机断层扫描在局限性先天性神经母细胞瘤自发消退中的临床价值:一项评估研究
Quant Imaging Med Surg. 2025 Aug 1;15(8):6682-6691. doi: 10.21037/qims-2025-524. Epub 2025 Jul 17.
8
Tertiary lymphoid structures-driven immune infiltration patterns and their association with survival in neuroblastoma.三级淋巴结构驱动的免疫浸润模式及其与神经母细胞瘤生存的关联。
PeerJ. 2025 Jul 22;13:e19767. doi: 10.7717/peerj.19767. eCollection 2025.
9
Roles and Impacts of Integrative Medical Interventions in Central Nervous System Tumor Treatment: Multi-Technology Convergence and the Paradigm Shift Toward Functional Reconstruction.综合医学干预在中枢神经系统肿瘤治疗中的作用与影响:多技术融合及向功能重建的范式转变
CNS Neurosci Ther. 2025 Jul;31(7):e70516. doi: 10.1111/cns.70516.
10
Combination of clinical parameters and I-metaiodobenzylguanidine scintigraphy in the monitoring of neuroblastoma metastases.临床参数与碘-间位碘代苄胍闪烁扫描术联合用于监测神经母细胞瘤转移
Quant Imaging Med Surg. 2025 Jun 6;15(6):5284-5295. doi: 10.21037/qims-24-1201. Epub 2025 Jun 3.